Cardiovascular perspectives of the TRP channel polycystin 2.

Calcium release from the endoplasmic reticulum is predominantly driven by two key ion channel receptors, Inositol 1, 4, 5-triphosphate receptor (InsP 3 R) in non-excitable cells and Ryanodine Receptor (RyR) in excitable and muscle-based cells. These calcium transients can be modified by other less-studied ion channels, including polycystin 2 (PC2), a member of the Transient Receptor Potential (TRP) family. PC2 is found in various cell types and is evolutionarily conserved with paralogs ranging from single-cell organisms to yeasts and mammals. Interest in the mammalian form of PC2 stems from its disease relevance, as mutations in the PKD2 gene, which encodes PC2, result in Autosomal Dominant Polycystic Kidney Disease (ADPKD). This disease is characterized by renal and liver cysts, and cardiovascular extrarenal manifestations. However, in contrast to the well-defined roles of many TRP channels, the role of PC2 remains unknown, as it has different subcellular locations, and the functional understanding of the channel in each location is still unclear. Recent structural and functional studies have shed light on this channel. Moreover, studies on cardiovascular tissues have demonstrated a diverse role of PC2 in these tissues compared to that in the kidney. We highlight recent advances in understanding the role of this channel in the cardiovascular system and discuss the functional relevance of PC2 in non-renal cells. Abstract figure legend The Transient Receptor Potential (TRP) channel polycystin 2 (PC2) allows for cation flux in a variety of subcellular locations including the primary cilia, plasma membrane and endoplasmic reticulum, ultimately contributing to cardiac and vascular contractility. This article is protected by copyright. All rights reserved.